Health Notices




3 JULY 2014 NEW ZEALAND GAZETTE, No. 70 1969

Product: SoluPrep Antiseptic Sponge (tinted)
Active Ingredients:
Chlorhexidine gluconate 2%w/v
Isopropyl alcohol 70%w/v
Dosage Form: Antiseptic solution
New Zealand Sponsor: 3M New Zealand Limited
Manufacturer: Laboratoire Atlas Inc, Quebec, Canada

Product: SoluPrep Antiseptic Swab (clear)
Active Ingredients:
Chlorhexidine gluconate 2%w/v
Isopropyl alcohol 70%v/v
Dosage Form: Antiseptic solution
New Zealand Sponsor: 3M New Zealand Limited
Manufacturer: Laboratoire Atlas Inc, Quebec, Canada

Product: SoluPrep Antiseptic Swab (tinted)
Active Ingredients:
Chlorhexidine gluconate 2%w/v
Isopropyl alcohol 70%v/v
Dosage Form: Antiseptic solution
New Zealand Sponsor: 3M New Zealand Limited
Manufacturer: Laboratoire Atlas Inc, Quebec, Canada

Product: SoluPrep Antiseptic Wipe
Active Ingredients:
Chlorhexidine gluconate 2%w/v
Isopropyl alcohol 70%v/v
Dosage Form: Antiseptic solution
New Zealand Sponsor: 3M New Zealand Limited
Manufacturer: Laboratoire Atlas Inc, Quebec, Canada

Dated this 26th day of June 2014.

SUSAN MARTINDALE, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

go4059

Provisional Consent to the Distribution of a New Medicine

Pursuant to section 23(1) of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:

Schedule

Product: HyperHep B
Active Ingredient: Hepatitis B immunoglobulin, human 220IU/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Medi’Ray New Zealand Limited
Manufacturer: Grifols Therapeutics Inc, North Carolina, United States of America

Note: This consent is valid for two years from the date of publication of this notice.

Dated this 26th day of June 2014.

SUSAN MARTINDALE, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

go4060

Misuse of Drugs Act 1975

Revocation of Notices Under Section 24 of the Misuse of Drugs Act 1975

Pursuant to section 24(7) of the Misuse of Drugs Act 1975, I, John Crawshaw, acting under delegated authority from the Minister of Health, revoke the approval of the Waikato District Health Board Community Alcohol and Drug Service and medical practitioner issued under this section on 13 March 2014.

Dated at Wellington this 29th day of June 2014.

DR JOHN CRAWSHAW, Director of Mental Health.

go4126

Approval of Waikato District Health Board Community Alcohol and Drug Service and Clinician to Provide Substitution Treatment Under Section 24 of the Misuse of Drugs Act 1975

Pursuant to section 24(7)(b) of the Misuse of Drugs Act 1975, I, John Crawshaw, acting under delegated authority from the Minister of Health, specify the Waikato District Health Board Community Alcohol and Drug Service (“Waikato CADS”) as a service that may provide treatment with controlled drugs for people who are dependent on controlled drugs, at the following places:

242 Bank Street
Te Awamutu 3800; and

Community Alcohol & Drug Service
193 London Street
Hamilton 3204; and



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2014, No 70





✨ LLM interpretation of page content

🏥 Consent to the Distribution of New Medicines (continued from previous page)

🏥 Health & Social Welfare
26 June 2014
Consent, Distribution, New Medicines, Medicines Act 1981, SoluPrep Antiseptic Sponge (tinted), SoluPrep Antiseptic Swab (clear), SoluPrep Antiseptic Swab (tinted), SoluPrep Antiseptic Wipe
  • SUSAN MARTINDALE, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013)

🏥 Provisional Consent to the Distribution of a New Medicine

🏥 Health & Social Welfare
26 June 2014
Provisional Consent, Distribution, New Medicine, Medicines Act 1981, HyperHep B
  • SUSAN MARTINDALE, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013)

🏥 Revocation of Notices Under Section 24 of the Misuse of Drugs Act 1975

🏥 Health & Social Welfare
29 June 2014
Revocation, Notices, Misuse of Drugs Act 1975, Waikato District Health Board Community Alcohol and Drug Service
  • DR JOHN CRAWSHAW, Director of Mental Health

🏥 Approval of Waikato District Health Board Community Alcohol and Drug Service and Clinician to Provide Substitution Treatment

🏥 Health & Social Welfare
29 June 2014
Approval, Waikato District Health Board Community Alcohol and Drug Service, Substitution Treatment, Misuse of Drugs Act 1975
  • DR JOHN CRAWSHAW, Director of Mental Health